Immunicom
Marilyn Panahi has over 25 years of lifescience industry experience in regulatory and manufacturing quality assurance. She has held various quality assurance leadership roles in both public and private lifescience companies in the San Diego area. She has extensive experience in implementation and management of GLP and GMP quality systems including: regulatory compliance; process control and process validation; change control and document control; internal and external audits; equipment calibration and validation; environmental monitoring; material management; deviation or OOS investigation; assay validation; batch release testing; product stability programs; and supporting regulatory submissions.
Marilyn received her Bachelors of Science degree in Microbiology from San Diego State University. Marilyn also completed University of California San Diego Specialized Certificate in Science of Regulatory Affairs for the Drug and Biologic Industry and another for Quality Assurance/Control for the Drug and Biologic Industry. She also completed Oriel Stat A Matrix Class for Quality Systems for Medical Devices: FDA’s QSR and ISO 13485.
Immunicom
Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy can allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments that may be used concurrently.